Мигрень у взрослых

Список литературы

Основные статьи

Evers S, Jensen R, European Federation of Neurological Societies. Treatment of medication overuse headache - guideline of the EFNS headache panel. Eur J Neurol. 2011 Sep;18(9):1115-21.Полный текст  Аннотация

Aurora SK, Dodick DW, Turkel CC, et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia. 2010 Jul;30(7):793-803. Аннотация

Schürks M, Rist PM, Bigal ME, et al. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ. 2009 Oct 27;339:b3914.Полный текст  Аннотация

Статьи, указанные как источники

1. Hadjikhani N, Sanchez Del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA. 2001 Apr 10;98(8):4687-92.Полный текст  Аннотация

2. Bashir A, Lipton RB, Ashina S, et al. Migraine and structural changes in the brain: a systematic review and meta-analysis. Neurology. 2013 Oct 1;81(14):1260-8.Полный текст  Аннотация

3. Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211.Полный текст  Аннотация

4. Steiner TJ, Stovner LJ, Birbeck GL. Migraine: the seventh disabler. J Headache Pain. 2013 Jan 10;14:1.Полный текст  Аннотация

5. Steiner TJ, Stovner LJ, Vos T. GBD 2015: migraine is the third cause of disability in under 50s. J Headache Pain. 2016 Dec;17(1):104.Полный текст  Аннотация

6. Stewart WF, Linet MS, Celentano DD, et al. Age- and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol. 1991 Nov 15;134(10):1111-20. Аннотация

7. Burch R, Rizzoli P, Loder E. The prevalence and impact of migraine and severe headache in the United States: figures and trends from government health studies. Headache. 2018 Apr;58(4):496-505.  Аннотация

8. Stovner IJ, Zwart, J-A, Hagen K, et al. Epidemiology of headache in Europe. Eur J Neurol. 2006 Apr;13(4):333-45. Аннотация

9. GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018 Nov;17(11):954-76.Полный текст  Аннотация

10. Charles A, Brennan KC. The neurobiology of migraine. Handb Clin Neurol. 2010;97:99-108.Полный текст  Аннотация

11. Cosentino G, Fierro B, Brighina F. From different neurophysiological methods to conflicting pathophysiological views in migraine: a critical review of literature. Clin Neurophysiol. 2014 Sep;125(9):1721-30. Аннотация

12. Pietrobon D. Calcium channels and migraine. Biochim Biophys Acta. 2013 Jul;1828(7):1655-65.Полный текст  Аннотация

13. Pietrobon D. Calcium channels and channelopathies of the central nervous system. Mol Neurobiol. 2002 Feb;25(1):31-50. Аннотация

14. Pietrobon D. Function and dysfunction of synaptic calcium channels: insights from mouse models. Curr Opin Neurobiol. 2005 Jun;15(3):257-65. Аннотация

15. Hans M, Luvisetto S, Williams ME, et al. Functional consequences of mutations in the human alpha1A calcium channel subunit linked to familial hemiplegic migraine. J Neurosci. 1999 Mar 1;19(5):1610-9. Аннотация

16. van den Maagdenberg AM, Pietrobon D, Pizzorusso T, et al. A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron. 2004 Mar 4;41(5):701-10. Аннотация

17. Pietrobon D, Streissnig J. Neurobiology of migraine. Nat Rev. 2003 May;4(5):386-98. Аннотация

18. Weiller C, May A, Limmroth V, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med. 1995 Jul;1(7):658-60. Аннотация

19. Bahra A, Matharu MS, Buchel C, et al. Brainstem activation specific to migraine headache. Lancet. 2001 Mar 31;357(9261):1016-7. Аннотация

20. Markowitz S, Saito K, Moskowitz MA. Neurogenically mediated plasma extravasation in dura mater: effect of ergot alkaloids. A possible mechanism of action in vascular headache. Cephalalgia. 1988 Jun;8(2):83-91. Аннотация

21. Buzzi MG, Moskowitz MA. Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine. Cephalalgia. 1991 Sep;11(4):165-8. Аннотация

22. Uddman R, Edvinsson L, Ekman R, et al. Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P. Neurosci Lett. 1985 Nov 20;62(1):131-6. Аннотация

23. Strassman AM, Raymond SA, Burstein R. Sensitization of meningeal sensory neurons and the origin of headaches. Nature. 1996 Dec 12;384(6609):560-4. Аннотация

24. Moskowitz MA, Cutrer FM. Sumatriptan: a receptor-targeted treatment for migraine. Annu Rev Med. 1993;44:145-54. Аннотация

25. Nozaki K, Boccalini P, Moskowitz MA. Expression of c-fos-like immunoreactivity in brainstem after meningeal irritation by blood in the subarachnoid space. Neuroscience. 1992 Aug;49(3):669-80. Аннотация

26. Kaube H, Keay KA, Hoskin KL, et al. Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat. Brain Res. 1993 Nov 26;629(1):95-102. Аннотация

27. Olesen J, Friberg L, Olsen TS, et al. Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol. 1990 Dec;28(6):791-8. Аннотация

28. Sanchez del Rio M, Bakker D, Wu O, et al. Perfusion weighted imaging during migraine: spontaneous visual aura and headache. Cephalalgia. 1999 Oct;19(8):701-7. Аннотация

29. Cutrer FM, Sorensen AG, Weisskoff RM, et al. Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann Neurol. 1998 Jan;43(1):25-31. Аннотация

30. Cao Y, Aurora SK, Nagesh V, et al. Functional MRI-BOLD of brainstem structures during visually triggered migraine. Neurology. 2002 Jul 9;59(1):72-8. Аннотация

31. Charles A, Brennan K. Cortical spreading depression-new insights and persistent questions. Cephalalgia. 2009 Oct;29(10):1115-24. Аннотация

32. Ashina M, Hansen JM, Do TP, et al. Migraine and the trigeminovascular system-40 years and counting. Lancet Neurol. 2019 Aug;18(8):795-804.Полный текст  Аннотация

33. Kandere-Grzybowska K, Gheorghe D, Priller J, et al. Stress-induced dura vascular permeability does not develop in mast cell-deficient and neurokinin-1 receptor knockout mice. Brain Res. 2003 Aug 8;980(2):213-20. Аннотация

34. Marcus DA, Furman JM. Prevention of motion sickness with rizatriptan: a double-blind, placebo-controlled pilot study. Med Sci Monit. 2006 Jan;12(1):1-7.Полный текст  Аннотация

35. Stewart WF, Bigal ME, Kolodner K, et al. Familial risk of migraine: variation by proband age at onset and headache severity. Neurology. 2006 Feb 14;66(3):344-8. Аннотация

36. Terwindt GM, Ophoff RA, van Eijk R, et al. Involvement of the CACNA1A gene containing region on 19p13 in migraine with and without aura. Neurology. 2001 Apr 24;56(8):1028-32. Аннотация

37. Pierelli F, Grieco GS, Pauri F, et al. A novel ATP1A2 mutation in a family with FHM type II. Cephalalgia. 2006 Mar;26(3):324-8. Аннотация

38. Vanmolkot KR, Kors EE, Turk U, et al. Two de novo mutations in the Na,K-ATPase gene ATP1A2 associated with pure familial hemiplegic migraine. Eur J Hum Genet. 2006 May;14(5):555-60.Полный текст  Аннотация

39. Dichgans M, Freilinger T, Eckstein G, et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet. 2005 Jul 30-Aug 5;366(9483):371-7. Аннотация

40. Gormley P, Kurki MI, Hiekkala ME, et al. Common variant burden contributes to the familial aggregation of migraine in 1,589 families. Neuron. 2018 May 16;98(4):743-53.e4.Полный текст  Аннотация

41. Rodriguez-Acevedo AJ, Ferreira MA, Benton MC, et al. Common polygenic variation contributes to risk of migraine in the Norfolk Island population. Hum Genet. 2015 Oct;134(10):1079-87. Аннотация

42. Scher AI, Stewart WF, Lipton RB. Caffeine as a risk factor for chronic daily headache: a population-based study. Neurology. 2004 Dec 14;63(11):2022-7. Аннотация

43. Mostofsky E, Mittleman MA, Buettner C, et al. Prospective cohort study of caffeinated beverage intake as a potential trigger of headaches among migraineurs. Am J Med. 2019 Aug;132(8):984-91. Аннотация

44. Bigal ME, Sheftell FD, Rapoport AM, et al. Chronic daily headache: identification of factors associated with induction and transformation. Headache. 2002 Jul-Aug;42(7):575-81. Аннотация

45. Arregui A, Cabrera J, Leon-Velarde F, et al. High prevalence of migraine in a high-altitude population. Neurology. 1991 Oct;41(10):1668-9. Аннотация

46. Mukamal KJ, Wellenius GA, Suh HH, et al. Weather and air pollution as triggers of severe headaches. Neurology. 2009 Mar 10;72(10):922-7.Полный текст  Аннотация

47. Scher AI, Stewart WF, Liberman J, et al. Prevalence of frequent headache in a population sample. Headache. 1998 Jul-Aug;38(7):497-506. Аннотация

48. Scher AI, Lipton RB, Stewart W. Risk factors for chronic daily headache. Curr Pain Headache Rep. 2002 Dec;6(6):486-91. Аннотация

49. Wang SJ, Fuh JL, Lu SR, et al. Chronic daily headache in Chinese elderly: prevalence, risk factors, and biannual follow-up. Neurology. 2000 Jan 25;54(2):314-9. Аннотация

50. Hagen K, Zwart JA, Vatten L, et al. Prevalence of migraine and non-migrainous headache - head-HUNT, a large population-based study. Cephalalgia. 2000 Dec;20(10):900-6. Аннотация

51. Westpheling J, Brawner M. Two transcribing activities are involved in expression of the Streptomyces galactose operon. J Bacteriol. 1989 Mar;171(3):1355-61.Полный текст  Аннотация

52. Ornello R, Ripa P, Pistoia F, et al. Migraine and body mass index categories: a systematic review and meta-analysis of observational studies. J Headache Pain. 2015 Mar 28;16:27.Полный текст  Аннотация

53. Bigal ME, Liberman JN, Lipton RB. Obesity and migraine: a population study. Neurology. 2006 Feb 28;66(4):545-50. Аннотация

54. Bigal ME, Lipton RB. Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology. 2006 Jul 25;67(2):252-7. Аннотация

55. Scher AI, Stewart WF, Ricci JA, et al. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain. 2003 Nov;106(1-2):81-9. Аннотация

56. Evers S, Jensen R, European Federation of Neurological Societies. Treatment of medication overuse headache - guideline of the EFNS headache panel. Eur J Neurol. 2011 Sep;18(9):1115-21.Полный текст  Аннотация

57. Rains JC. Sleep and migraine: assessment and treatment of comorbid sleep disorders. headache. 2018 Jul;58(7):1074-91. Аннотация

58. Martin VT, Vij B. Diet and headache: part 1. Headache. 2016 Oct;56(9):1543-52. Аннотация

59. Maghsoumi-Norouzabad L, Mansoori A, Abed R, et al. Effects of omega-3 fatty acids on the frequency, severity, and duration of migraine attacks: a systematic review and meta-analysis of randomized controlled trials. Nutr Neurosci. 2018 Nov;21(9):614-23. Аннотация

60. Byyny RL, Mower WR, Shum N, et al. Sensitivity of noncontrast cranial computed tomography for the emergency department diagnosis of subarachnoid hemorrhage. Ann Emerg Med. 2008 Jun;51(6):697-703. Аннотация

61. Lavi R, Yarnitsky D, Rowe JM, et al. Standard vs atraumatic Whitacre needle for diagnostic lumbar puncture: a randomized trial. Neurology. 2006 Oct 24;67(8):1492-4. Аннотация

62. Arendt K, Demaerschalk BM, Wingerchuk DM, Camann W. Atraumatic lumbar puncture needles: after all these years, are we still missing the point? Neurologist. 2009 Jan;15(1):17-20. Аннотация

63. Nath S, Koziarz A, Badhiwala JH, et al. Atraumatic versus conventional lumbar puncture needles: a systematic review and meta-analysis. Lancet. 2018 Mar 24;391(10126):1197-204. Аннотация

64. Rochwerg B, Almenawer SA, Siemieniuk RAC, et al. Atraumatic (pencil-point) versus conventional needles for lumbar puncture: a clinical practice guideline. BMJ. 2018 May 22;361:k1920.Полный текст  Аннотация

65. Ahmed SV, Jayawarna C, Jude E. Post lumbar puncture headache: diagnosis and management. Postgrad Med J. 2006 Nov;82(973):713-6.Полный текст  Аннотация

66. Arevalo-Rodriguez I, Ciapponi A, Roqué i Figuls M, et al. Posture and fluids for preventing post-dural puncture headache. Cochrane Database Syst Rev. 2016 Mar 7;(3):CD009199.Полный текст  Аннотация

67. Smetana GW. The diagnostic value of historical features in primary headache syndromes: a comprehensive review. Arch Intern Med. 2000 Oct 9;160(18):2729-37.Полный текст  Аннотация

68. Amin FM, Aristeidou S, Baraldi C, et al. The association between migraine and physical exercise. J Headache Pain. 2018 Sep 10;19(1):83.Полный текст  Аннотация

69. Linn FH, Wijdicks EF. Causes and management of thunderclap headache: a comprehensive review. Neurologist. 2002 Sep;8(5):279-89. Аннотация

70. Detsky ME, McDonald DR, Baerlocher MO, et al. Does this patient with headache have a migraine or need neuroimaging? JAMA. 2006 Sep 13;296(10):1274-83. Аннотация

71. Silberstein SD, Saper JR, Freitag F. Migraine: diagnosis and treatment. In: Silberstein SD, Saper JR, Freitag F, eds. Wolff's headache and other head pain. 7th ed. New York, NY: Oxford University Press; 2001:128-30.

72. D'Amico D, Leone M, Bussone G. Side-locked unilaterality and pain localization in long-lasting headaches: migraine, tension-type headache, and cervicogenic headache. Headache. 1994 Oct;34(9):526-30. Аннотация

73. Sjaastad O, Fredriksen TA, Sand T, et al. Unilaterality of headache in classic migraine. Cephalalgia. 1989 Mar;9(1):71-7. Аннотация

74. Tierney LM, McPhee SJ, Papadakis MA (editors). Current medical diagnosis and treatment 2004. 43rd ed. New York: Lange Medical Books/McGraw-Hill; 2004.

75. Mokri B. Spontaneous low cerebrospinal pressure/volume headaches. Curr Neurol Neurosci Rep. 2004 Mar;4(2):117-24. Аннотация

76. Mokri B. Posture-related headaches and pachymeningeal enhancement in CSF leaks from craniotomy site. Cephalalgia. 2001 Dec;21(10):976-9. Аннотация

77. Mokri B. Cerebrospinal fluid volume depletion and its emerging clinical/imaging syndromes. Neurosurg Focus. 2000 Jul 15;9(1):e6. Аннотация

78. Lipton RB, Cady RK, Stewart WF, et al. Diagnostic lessons from the spectrum study. Neurology. 2002 May 14;58(9 suppl 6):S27-31. Аннотация

79. Tepper SJ, Dahlof CG, Dowson A, et al. Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of headache: data from the Landmark Study. Headache. 2004 Oct;44(9):856-64. Аннотация

80. Kaniecki RG. Migraine and tension-type headache: an assessment of challenges in diagnosis. Neurology. 2002 May 14;58(9 suppl 6):S15-20. Аннотация

81. Schürks M, Kurth T, de Jesus J. Cluster headache: clinical presentation, lifestyle features, and medical treatment. Headache. 2006 Sep;46(8):1246-54. Аннотация

82. May A, Goadsby PJ. Hypothalamic involvement and activation in cluster headache. Curr Pain Headache Rep. 2001 Feb;5(1):60-6. Аннотация

83. Drummond PD. Photophobia and autonomic responses to facial pain in migraine. Brain. 1997 Oct;120 (Pt 10):1857-64. Аннотация

84. Cortelli P, Pierangeli G. Chronic pain-autonomic interactions. Neurol Sci. 2003 May;24(suppl 2):S68-70. Аннотация

85. Barbanti P, Fabbrini G, Pesare M, et al. Unilateral cranial autonomic symptoms in migraine. Cephalalgia. 2002 May;22(4):256-9. Аннотация

86. Edlow JA. Diagnosis of subarachnoid hemorrhage in the emergency department. Emerg Med Clin North Am. 2003 Feb;21(1):73-87. Аннотация

87. Rosenberg JH, Silberstein SD. The headache of SAH responds to sumatriptan. Headache. 2005 May;45(5):597-8.598. Аннотация

88. Purdy RA, Kirby S. Headaches and brain tumors. Neurol Clin. 2004 Feb;22(1):39-53. Аннотация

89. Mokri B. Headaches caused by decreased intracranial pressure: diagnosis and management. Curr Opin Neurol. 2003 Jun;16(3):319-26. Аннотация

90. Schievink WI. Spontaneous spinal cerebrospinal fluid leaks. Cephalalgia. 2008 Dec;28(12):1345-56. Аннотация

91. Ramadan NM. Headache caused by raised intracranial pressure and intracranial hypotension. Curr Opin Neurol. 1996 Jun;9(3):214-8. Аннотация

92. Sengupta S, Eckstein C, Collins T. The dilemma of diagnosing idiopathic intracranial hypertension without papilledema in patients with chronic migraine. JAMA Neurol. 2019 Jul 1 [Epub ahead of print].  Аннотация

93. Azuaje C, Fernandez Hidalgo N, Almirante B, et al. Tuberculous meningitis: a comparative study in relation to concurrent human immunodeficiency virus infection [in Spanish]. Enferm Infecc Microbiol Clin. 2006 Apr;24(4):245-50. Аннотация

94. Soto-Hernandez JL, Moreno-Andrade T, Gongora-Rivera F, et al. Nocardia abscess during treatment of brain toxoplasmosis in a patient with AIDS, utility of proton MR spectroscopy and diffusion-weighted imaging in diagnosis. Clin Neurol Neurosurg. 2006 Jul;108(5):493-8. Аннотация

95. Tsai SH, Chu SJ, Wu CP, et al. Listerial meningitis in a patient with undiagnosed acquired immunodeficiency syndrome: ampicillin should be added to the empirical antibiotic coverage. Emerg Med J. 2006 Sep;23(9):e50. Аннотация

96. Silberstein SD. Headaches due to nasal and paranasal sinus disease. Neurol Clin. 2004 Feb;22(1):1-19. Аннотация

97. Fox GN. Giant cell arteritis. CMAJ. 2005 Dec 6;173(12):1490.Полный текст  Аннотация

98. Pinnell J, Tiivas C, Perkins P, et al. Ultrasonography of occipital arteries to diagnose giant cell arteritis: a case series and literature review. Clin Rheumatol. 2018 Feb;37(2):569-73. Аннотация

99. De Giuli V, Grassi M, Lodigiani C, et al. Association between migraine and cervical artery dissection: the Italian Project on Stroke in Young Adults. JAMA Neurol. 2017 May 1;74(5):512-8. Аннотация

100. Evans RW, Mokri B. Headache in cervical artery dissections. Headache. 2002 Nov-Dec;42(10):1061-3. Аннотация

101. Mokri B, Piepgras DG, Houser OW. Traumatic dissections of the extracranial internal carotid artery. J Neurosurg. 1988 Feb;68(2):189-97. Аннотация

102. Newman DS, Levine SR, Curtis VL, et al. Migraine-like visual phenomena associated with cerebral venous thrombosis. Headache. 1989 Feb;29(2):82-5. Аннотация

103. Tietjen GE. The risk of stroke in patients with migraine and implications for migraine management. CNS Drugs. 2005;19(8):683-92. Аннотация

104. Bousser MG, Conard J, Kittner S, et al. Recommendations on the risk of ischaemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine. The International Headache Society Task Force on Combined Oral Contraceptives and Hormone Replacement Therapy. Cephalalgia. 2000 Apr;20(3):155-6. Аннотация

105. Gonzalez-Martinez F, Navarro-Gutierrez S, Oliete-Ramirez E, et al. Stroke in young patients: a diagnostic challenge in the emergency room. Eur J Emerg Med. 2004 Jun;11(3):178-80. Аннотация

106. Agostoni E, Aliprandi A. The complications of migraine with aura. Neurol Sci. 2006 May;27(suppl 2):S91-5. Аннотация

107. Lipton RB, Dodick D, Sadovsky R, et al. A self-administered screener for migraine in primary care: the ID Migraine validation study. Neurology. 2003 Aug 12;61(3):375-82. Аннотация

108. Lipton RB, Bigal ME, Amatniek JC, et al. Tools for diagnosing migraine and measuring its severity. Headache. 2004 May;44(5):387-98. Аннотация

109. Haag G, Diener HC, May A, et al. Self-medication of migraine and tension-type headache: summary of the evidence-based recommendations of the Deutsche Migrane und Kopfschmerzgesellschaft (DMKG), the Deutsche Gesellschaft fur Neurologie (DGN), the Osterreichische Kopfschmerzgesellschaft (OKSG) and the Schweizerische Kopfwehgesellschaft (SKG). J Headache Pain. 2011 Apr;12(2):201-17.Полный текст  Аннотация

110. Snow V, Weiss K, Wall EM, et al; American Academy of Family Physicians; American College of Physicians-American Society of Internal Medicine. Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Ann Intern Med. 2002 Nov 19;137(10):840-9.Полный текст  Аннотация

111. Derry S, Rabbie R, Moore RA. Diclofenac with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2013 Apr 30;(4):CD008783.Полный текст  Аннотация

112. MacGregor A. Migraine associated with menstruation. Funct Neurol. 2000;15(suppl 3):143-53. Аннотация

113. Lipton RB, Grosberg B, Singer RP, et al. Efficacy and tolerability of a new powdered formulation of diclofenac potassium for oral solution for the acute treatment of migraine: Results from the International Migraine Pain Assessment Clinical Trial (IMPACT). Cephalalgia. 2010 Nov;30(11):1336-45. Аннотация

114. Rabbie RD, Derry S, Moore RA. Ibuprofen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2013 Apr 30;(4):CD008039.Полный текст  Аннотация

115. Suthisisang CC, Poolsup N, Suksomboon N, et al. Meta-analysis of the efficacy and safety of naproxen sodium in the acute treatment of migraine. Headache. 2010 May;50(5):808-18. Аннотация

116. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000 Sep 26;55(6):754-62. [Erratum in: Neurology 2000 Jan 9;56(1):142.]Полный текст  Аннотация

117. Lipton RB, Silberstein SD. The role of headache-related disability in migraine management: implications for headache treatment guidelines. Neurology. 2001;56(6 suppl 1):S35-42. Аннотация

118. Derry CJ, Derry S, Moore RA. Sumatriptan (oral route of administration) for acute migraine attacks in adults. Cochrane Database Syst Rev. 2012 Feb 15;(2):CD008615.Полный текст  Аннотация

119. Thorlund K, Toor K, Wu P, et al. Comparative tolerability of treatments for acute migraine: a network meta-analysis. Cephalalgia. 2017 Sep;37(10):965-78. Аннотация

120. Cady RK, Wendt JK, Kirchner JR, et al. Treatment of acute migraine with subcutaneous sumatriptan. JAMA. 1991 Jun 5;265(21):2831-5. Аннотация

121. Derry CJ, Derry S, Moore RA. Sumatriptan (intranasal route of administration) for acute migraine attacks in adults. Cochrane Database Syst Rev. 2012 Feb 15;(2):CD009663.Полный текст  Аннотация

122. Derry CJ, Derry S, Moore RA. Sumatriptan (rectal route of administration) for acute migraine attacks in adults. Cochrane Database Syst Rev. 2012 Feb 15;(2):CD009664.Полный текст  Аннотация

123. Menshawy A, Ahmed H, Ismail A, et al. Intranasal sumatriptan for acute migraine attacks: a systematic review and meta-analysis. Neurol Sci. 2018 Jan;39(1):31-44. Аннотация

124. Ferrari MD, Roon KI, Lipton RB, et al. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet. 2001 Nov 17;358(9294):1668-75. Аннотация

125. Derry S, Moore RA. Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2013 Apr 30;(4):CD008040.Полный текст  Аннотация

126. Goldstein J, Silberstein SD, Saper JR, et al. Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled study. Headache. 2006 Mar;46(3):444-53. Аннотация

127. Blumenthal HJ, Diamond ML. Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial - a comment. Headache. 2006 Feb;46(2):340. Аннотация

128. Diener HC, Pfaffenrath V, Pageler L, et al. The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia. 2005 Oct;25(10):776-87. Аннотация

129. Lipton RB, Diener HC, Robbins MS, et al. Caffeine in the management of patients with headache. J Headache Pain. 2017 Oct 24;18(1):107.Полный текст  Аннотация

130. Cady RK, Sheftell F, Lipton RB, et al. Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials. Clin Ther. 2000 Sep;22(9):1035-48. Аннотация

131. Cady RK, Lipton RB, Hall C, et al. Treatment of mild headache in disabled migraine sufferers: results of the Spectrum Study. Headache. 2000 Nov-Dec;40(10):792-7. Аннотация

132. Foley KA, Cady R, Martin V, et al. Treating early versus treating mild: timing of migraine prescription medications among patients with diagnosed migraine. Headache. 2005 May;45(5):538-45. Аннотация

133. Ozkurt B, Cinar O, Cevik E, et al. Efficacy of high-flow oxygen therapy in all types of headache: a prospective, randomized, placebo-controlled trial. Amer J Emerg Med. 2012 Nov;30(9):1760-4. Аннотация

134. Smith TR, Sunshine A, Stark SR, et al. Sumatriptan and naproxen sodium for the acute treatment of migraine. Headache. 2005 Sep;45(8):983-91. Аннотация

135. Loder E. Fixed drug combinations for the acute treatment of migraine: place in therapy. CNS Drugs. 2005;19(9):769-84. Аннотация

136. Krymchantowski AV, Filho PF, Bigal ME. Rizatriptan vs. rizatriptan plus trimebutine for the acute treatment of migraine: a double-blind, randomized, cross-over, placebo-controlled study. Cephalalgia. 2006 Jul;26(7):871-4. Аннотация

137. Krymchantowski AV, Bigal ME. Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine. BMC Neurol. 2004 Jun 28;4:10.Полный текст  Аннотация

138. Peroutka SJ. Beyond monotherapy: rational polytherapy in migraine. Headache. 1998 Jan;38(1):18-22. Аннотация

139. Kelly AM, Walcynski T, Gunn B. The relative efficacy of phenothiazines for the treatment of acute migraine: a meta-analysis. Headache. 2009 Oct;49(9):1324-32. Аннотация

140. Bigal ME. Phenothiazines in migraine treatment. Curr Pain Headache Rep. 2010 Aug;14(4):253-5. Аннотация

141. Orr SL, Friedman BW, Christie SC, et al. Management of adults with acute migraine in the emergency department: the American Headache Society evidence assessment of parenteral pharmacotherapies. Headache. 2016 Jun;56(6):911-40.Полный текст  Аннотация

142. Friedman BW, Irizarry E, Solorzano C, et al. Randomized study of IV prochlorperazine plus diphenhydramine vs IV hydromorphone for migraine. Neurology. 2017 Nov 14;89(20):2075-82. Аннотация

143. Friedman BW, Cabral L, Adewunmi V, et al. Diphenhydramine as adjuvant therapy for acute migraine: an emergency department-based randomized clinical trial. Ann Emerg Med. 2016 Jan;67(1):32-9.e3.Полный текст  Аннотация

144. D'Souza RS, Mercogliano C, Ojukwu E, et al. Effects of prophylactic anticholinergic medications to decrease extrapyramidal side effects in patients taking acute antiemetic drugs: a systematic review and meta-analysis. Emerg Med J. 2018 May;35(5):325-31.Полный текст  Аннотация

145. Kelley NE, Tepper DE. Rescue therapy for acute migraine, part 2: neuroleptics, antihistamines, and others. Headache. 2012 Feb;52(2):292-306.Полный текст  Аннотация

146. European Medicines Agency. New measures to avoid valproate exposure in pregnancy endorsed. EMA/145600/2018. March 2018 [internet publication].Полный текст

147. Kelly AM. Migraine: pharmacotherapy in the emergency department. West J Med. 2000 Sep;173(3):189-93.Полный текст  Аннотация

148. Ramadan NM, Halvorson H, Vande-Linde A, et al. Low brain magnesium in migraine. Headache. 1989 Oct;29(9):590-3. Аннотация

149. Boska MD, Welch KM, Barker PB, et al. Contrasts in cortical magnesium, phospholipid and energy metabolism between migraine syndromes. Neurology. 2002 Apr 23;58(8):1227-33. Аннотация

150. Smeets MC, Vernooy CB, Souverijn JH, et al. Intracellular and plasma magnesium in familial hemiplegic migraine and migraine with and without aura. Cephalalgia. 1994 Feb;14(1):29-32. Аннотация

151. Choi H, Parmar N. The use of intravenous magnesium sulphate for acute migraine: meta-analysis of randomized controlled trials. Eur J Emerg Med. 2014 Feb;21(1):2-9. Аннотация

152. US Food and Drug Administration. FDA recommends against prolonged use of magnesium sulfate to stop pre-term labor due to bone changes in exposed babies. May 2013 [internet publication].Полный текст

153. Magnoux E, Zlotnik G. Outpatient intravenous dihydroergotamine for refractory cluster headache. Headache. 2004 Mar;44(3):249-55. Аннотация

154. Tfelt-Hansen P, Saxena PR, Dahlof C, et al. Ergotamine in the acute treatment of migraine: a review and European consensus. Brain. 2000 Jan;123(Pt 1):9-18.Полный текст  Аннотация

155. Evers S, Afra J, Frese A, et al. EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force. Eur J Neurol. 2009 Sep;16(9):968-81.Полный текст  Аннотация

156. Derosier FS, Sheftell F, Silberstein S, et al. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study. Headache. 2012 Apr;52(4):530-43. Аннотация

157. Gerhardt RT, Hermstad E, Crawford DM, et al. Postdischarge secobarbital after ED migraine treatment decreases pain and improves resolution. Am J Emerg Med. 2011 Jan;29(1):86-90. Аннотация

158. Webster J, Osborne S, Rickard CM, et al. Clinically-indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database Syst Rev. 2019 Jan 23;(1):CD007798.Полный текст  Аннотация

159. Pryse-Phillips WE, Dodick DW, Edmeads JG, et al. Guidelines for the nonpharmacologic management of migraine in clinical practice. Canadian Headache Society. CMAJ. 1998 Jul 14;159(1):47-54.Полный текст  Аннотация

160. Holroyd KA, Penzien DB. Psychosocial interventions in the management of recurrent headache disorders. 1: Overview and effectiveness. Behav Med. 1994 Summer;20(2):53-63. Аннотация

161. Marcus DA, Scharff L, Turk DC. Nonpharmacological management of headaches during pregnancy. Psychosom Med. 1995 Nov-Dec;57(6):527-35. Аннотация

162. Probyn K, Bowers H, Caldwell F, et al. Prognostic factors for chronic headache: a systematic review. Neurology. 2017 Jul;89(3): 291-301.Полный текст  Аннотация

163. Kropp P, Meyer B, Meyer W, et al. An update on behavioral treatments in migraine - current knowledge and future options. Expert Rev Neurother. 2017 Nov;17(11):1059-68. Аннотация

164. Sharpe L, Dudeney J, Williams ACC, et al. Psychological therapies for the prevention of migraine in adults. Cochrane Database Syst Rev. 2019 Jul 2;(7):CD012295.Полный текст  Аннотация

165. Biondi DM. Physical treatments for headache: a structured review. Headache. 2005 Jun;45(6):738-46. Аннотация

166. Chaibi AT, Tuchin PJ, Russell MB. Manual therapies for migraine: a systematic review. J Headache Pain. 2011 Apr;12(2):127-33.Полный текст  Аннотация

167. Posadzki PE, Ernst E. Spinal manipulations for the treatment of migraine: a systematic review of randomized clinical trials. Cephalalgia. 2011 Jun;31(8):964-70. Аннотация

168. Lemmens J, De Pauw J, Van Soom T, et al. The effect of aerobic exercise on the number of migraine days, duration and pain intensity in migraine: a systematic literature review and meta-analysis. J Headache Pain. 2019 Feb 14;20(1):16.Полный текст  Аннотация

169. Linde K, Allais G, Brinkhaus B, et al. Acupuncture for the prevention of episodic migraine. Cochrane Database Syst Rev. 2016 Jun 28;(6):CD001218.Полный текст  Аннотация

170. MacPherson H, Vickers A, Bland M, et al. Acupuncture for chronic pain and depression in primary care: a programme of research. Southampton (UK): NIHR Journals Library; 2017 Jan.Полный текст  Аннотация

171. Xu J, Zhang FQ, Pei J, et al. Acupuncture for migraine without aura: a systematic review and meta-analysis. J Integr Med. 2018 Sep;16(5):312-21. Аннотация

172. Silberstein SD, Lipton RB, Goadsby PJ. Headache in clinical practice. 2nd ed. Oxford: Martin Dunitz; 2002.

173. Evans RW, Loder E, Biondi DM. When can successful migraine prophylaxis be discontinued? Headache. 2004 Nov-Dec;44(10):1040-2. Аннотация

174. Rizzoli P, Loder EW. Tolerance to the beneficial effects of prophylactic migraine drugs: a systematic review of causes and mechanisms. Headache. 2011 Sep;51(8):1323-35. Аннотация

175. Loder E, Burch R, Rizzoli P. The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines. Headache. 2012 Jun;52(6):930-45. Аннотация

176. Couch JR, Ziegler DK, Hassanein R. Amitriptyline in the prophylaxis of migraine. Effectiveness and relationship of antimigraine and antidepressant effects. Neurology. 1976 Feb;26(2):121-7. Аннотация

177. Silberstein SD. Tricyclic antidepressant medication, stress management therapy, and their combination in the management of chronic tension-type headache. Curr Neurol Neurosci Rep. 2002 Mar;2(2):105-7. Аннотация

178. Ziegler DK, Hurwitz A, Hassanein RS, et al. Migraine prophylaxis. A comparison of propranolol and amitriptyline. Arch Neurol. 1987 May;44(5):486-9. Аннотация

179. Diener HC, Hartung E, Chrubasik J, et al. A comparative study of oral acetylsalicylic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, double-blind, parallel group phase III study. Cephalalgia. 2001 Mar;21(2):120-8. Аннотация

180. Diener HC, Brune K, Gerber WD, et al. Treatment of migraine attacks and migraine prophylaxis: recommendations of the German Migraine and Headache Society [in German]. Med Monatsschr Pharm. 1998 Feb;21(2):30-9. Аннотация

181. Gerber WD, Diener HC, Scholz E, et al. Responders and non-responders to metoprolol, propranolol and nifedipine treatment in migraine prophylaxis: a dose-range study based on time-series analysis. Cephalalgia. 1991 Feb;11(1):37-45. Аннотация

182. Andersson KE, Vinge E. Beta-adrenoceptor blockers and calcium antagonists in the prophylaxis and treatment of migraine. 1990 Mar;39(3):355-73. Аннотация

183. Holroyd KA, France JL, Cordingley GE, et al. Enhancing the effectiveness of relaxation-thermal biofeedback training with propranolol hydrochloride. J Consult Clin Psychol. 1995 Apr;63(2):327-30. Аннотация

184. Ekbom K. Alprenolol for migraine prophylaxis. Headache. 1975 Jul;15(2):129-32. Аннотация

185. Lastimosa AC. Treatment of sporadic hemiplegic migraine with calcium-channel blocker verapamil. Neurology. 2003 Sep 9;61(5):721-2. Аннотация

186. Yu W, Horowitz SH. Familial hemiplegic migraine and its abortive therapy with intravenous verapamil. Neurology. 2001 Nov 13;57(9):1732-3. Аннотация

187. Greenberg DA. Calcium channel antagonists and the treatment of migraine. Clin Neuropharmacol. 1986;9(4):311-28. Аннотация

188. Silberstein SD, Holland S, Freitag F, et al. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults. Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012;78:1337-1345.Полный текст  Аннотация

189. Hoffert MJ, Scholz MJ, Kanter R. A double-blind controlled study of nifedipine as an abortive treatment in acute attacks of migraine with aura. Cephalalgia. 1992 Oct;12(5):323-4. Аннотация

190. Zhu Y, Liu Y, Zhao J, et al. The efficacy and safety of calcitonin gene-related peptide monoclonal antibody for episodic migraine: a meta-analysis. Neurol Sci. 2018 Dec;39(12):2097-106. Аннотация

191. Sacco S, Bendtsen L, Ashina M, et al. European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention. J Headache Pain. 2019 Jan 16;20(1):6.Полный текст  Аннотация

192. Dodick DW, Ashina M, Brandes JL, et al. ARISE: a phase 3 randomized trial of erenumab for episodic migraine. Cephalalgia. 2018 May;38(6):1026-37. Аннотация

193. Tepper S, Ashina M, Reuter U, et al. Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurol. 2017 Jun;16(6):425-34. Аннотация

194. Reuter U, Goadsby PJ, Lanteri-Minet M, et al. Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study. Lancet. 2018 Nov 24;392(10161):2280-7. Аннотация

195. Silberstein SD, Dodick DW, Bigal ME, et al. Fremanezumab for the preventive treatment of chronic migraine. N Engl J Med. 2017 Nov 30;377(22):2113-22.Полный текст  Аннотация

196. Dodick DW, Silberstein SD, Bigal ME, et al. Effect of fremanezumab compared with placebo for prevention of episodic migraine: a randomized clinical trial. JAMA. 2018 May 15;319(19):1999-2008. Аннотация

197. Stauffer VL, Dodick DW, Zhang Q, et al. Evaluation of galcanezumab for the prevention of episodic migraine: the EVOLVE-1 randomized clinical trial. JAMA Neurol. 2018 Sep 1;75(9):1080-8.Полный текст  Аннотация

198. Skljarevski V, Matharu M, Millen BA, et al. Efficacy and safety of galcanezumab for the prevention of episodic migraine: results of the EVOLVE-2 Phase 3 randomized controlled clinical trial. Cephalalgia. 2018 Jul;38(8):1442-54. Аннотация

199. Aurora SK, Dodick DW, Turkel CC, et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia. 2010 Jul;30(7):793-803. Аннотация

200. Diener HC, Dodick DW, Aurora SK, et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia. 2010 Jul;30(7):804-14. Аннотация

201. Aurora SK, Winner P, Freeman MC, et al. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program. Headache. 2011 Oct;51(9):1358-73. Аннотация

202. Jackson JL, Kuriyama A, Hayashino Y. Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis. JAMA. 2012 Apr 25;307(16):1736-45. Аннотация

203. Diener HC, Dodick DW, Turkel CC, et al. Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraine. Eur J Neurol. 2014 Jun;21(6):851-9.Полный текст  Аннотация

204. Lipton RB, Varon SF, Grosberg B, et al. OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine. Neurology. 2011 Oct 11;77(15):1465-72. Аннотация

205. Sacco S, Merki-Feld GS, Ægidius KL, et al. Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC). J Headache Pain. 2017 Oct 30;18(1):108.Полный текст  Аннотация

206. Maasumi K, Tepper SJ, Kriegler JS. Menstrual migraine and treatment options: review. Headache. 2017 Feb;57(2):194-208. Аннотация

207. Allais G, Chiarle G, Sinigaglia S, et al. Menstrual migraine: a review of current and developing pharmacotherapies for women. Expert Opin Pharmacother. 2018 Feb;19(2):123-36. Аннотация

208. Mauskop A, Altura BT, Altura BM. Serum ionized magnesium levels and serum ionized calcium/ionized magnesium ratios in women with menstrual migraine. Headache. 2002 Apr;42(4):242-8. Аннотация

209. von Luckner A, Riederer F. Magnesium in migraine prophylaxis - is there an evidence-based rationale? A systematic review. Headache. 2018 Feb;58(2):199-209. Аннотация

210. Tepper D. Pregnancy and lactation - migraine management. Headache. 2015 Apr;55(4):607-8.Полный текст  Аннотация

211. Volpe FM. An 8-week, open-label trial of duloxetine for comorbid major depressive disorder and chronic headache. J Clin Psychiatry. 2008 Sep;69(9):1449-54. Аннотация

212. Burch R. Antidepressants for preventive treatment of migraine. Curr Treat Options Neurol. 2019 Mar 21;21(4):18. Аннотация

213. Ambrosini A, Schoenen J. Invasive pericranial nerve interventions. Cephalalgia. 2016 Oct;36(12):1156-69.Полный текст  Аннотация

214. Goldstein J, Silberstein SD, Saper JR, et al. Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial. Headache. 2005 Sep;45(8):973-82. Аннотация

215. Diener HC, Lampl C, Reimnitz P, et al. Aspirin in the treatment of acute migraine attacks. Expert Rev Neurother. 2006 Apr;6(4):563-73. Аннотация

216. Krymchantowski AV, Peixoto P, Higashi R, et al. Lysine clonixinate vs naproxen sodium for the acute treatment of migraine: a double-blind, randomized, crossover study. MedGenMed. 2005 Dec 14;7(4):69.Полный текст  Аннотация

217. Ghelardini C, Galeotti N, Grazioli I, et al. Indomethacin, alone and combined with prochlorperazine and caffeine, but not sumatriptan, abolishes peripheral and central sensitization in in vivo models of migraine. J Pain. 2004 Oct;5(8):413-9. Аннотация

218. Wenzel RG, Sarvis CA. Do butalbital-containing products have a role in the management of migraine? Pharmacotherapy. 2002 Aug;22(8):1029-35. Аннотация

219. Silberstein SD, McCrory DC. Butalbital in the treatment of headache: history, pharmacology, and efficacy. Headache. 2001 Nov-Dec;41(10):953-67. Аннотация

220. Lanas A. Prevention and treatment of NSAID-induced gastroduodenal injury. Curr Treat Options Gastroenterol. 2006 Apr;9(2):147-56. Аннотация

221. Peng S, Duggan A. Gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs. Expert Opin Drug Saf. 2005 Mar;4(2):157-69. Аннотация

222. Herings RM, Goettsch WG. Inadequate prevention of NSAID-induced gastrointestinal events. Ann Pharmacother. 2004 May;38(5):760-3. Аннотация

223. Rahman A, Segasothy M, Samad SA, et al. Analgesic use and chronic renal disease in patients with headache. Headache. 1993 Sep;33(8):442-5. Аннотация

224. Vaughan JV, Fleischl P, Nathan M, et al. Chronic renal disease and analgesic abuse. N Z Med J. 1967 Nov;66(424):794-7. Аннотация

225. European Medicines Agency. European Medicines Agency recommends changes to the use of metoclopramide. July 2013 [internet publication].Полный текст

226. Bhatia MS, Gupta R, Srivastava S. Migraine associated with water deprivation and progressive myopia. Cephalalgia. 2006 Jun;26(6):758-60. Аннотация

227. Blau JN. Water deprivation: a new migraine precipitant. Headache. 2005 Jun;45(6):757-9. Аннотация

228. Spigt MG, Kuijper EC, Schayck CP, et al. Increasing the daily water intake for the prophylactic treatment of headache: a pilot trial. Eur J Neurol. 2005 Sep;12(9):715-8. Аннотация

229. Pfaffenrath V, Rehm M. Migraine in pregnancy: what are the safest treatment options? Drug Saf. 1998 Nov;19(5):383-8. Аннотация

230. Lopez P, Aguilera C. Safety of antimigraine drugs during pregnancy [in Spanish]. Med Clin (Barc). 2006 May 27;126(20):793-5. Аннотация

231. Fox AW, Diamond ML, Spierings EL. Migraine during pregnancy: options for therapy. CNS Drugs. 2005;19(6):465-81. Аннотация

232. Conner SJ, Rideout S, Elliott TC. Clinical Inquiries. What are the best therapies for acute migraine in pregnancy? J Fam Pract. 2005 Nov;54(11):992-5. Аннотация

233. The dangers of acetaminophen. Health News. 2006 Jun;12(6):4. Аннотация

234. Blendis L. Unintentional acetaminophen-induced acute liver failure in the U.S.: time for action? Gastroenterology. 2006 Sep;131(3):963-4. Аннотация

235. Fontana RJ, Quallich LG. Acute liver failure. Curr Opin Gastroenterol. 2001 May;17(3):291-8. Аннотация

236. Moling O, Cairon E, Rimenti G, et al. Severe hepatotoxicity after therapeutic doses of acetaminophen. Clin Ther. 2006 May;28(5):755-60. Аннотация

237. Cady RK, Sheftell F, Lipton RB, et al. Economic implications of early treatment of migraine with sumatriptan tablets. Clin Ther. 2001 Feb;23(2):284-91. Аннотация

238. Halpern MT, Lipton RB, Cady RK, et al. Costs and outcomes of early versus delayed migraine treatment with sumatriptan. Headache. 2002 Nov-Dec;42(10):984-99. Аннотация

239. Daz-Insa S, Goadsby PJ, Zanchin G, et al. The impact of allodynia on the efficacy of almotriptan when given early in migraine: data from the "act when mild" study. Int J Neurosci. 2011 Dec;121(12):655-61. Аннотация

240. Loder E. Safety of sumatriptan in pregnancy: a review of the data so far. CNS Drugs. 2003;17(1):1-7. Аннотация

241. Loder E, Biondi D. Can this patient take a triptan? Review of the cardiovascular safety of the triptans and recommendations for patient selection and evaluation. Internet J Neurol. 2004;3:1-15.Полный текст

242. White WB, Derosier FJ, Thompson AH, et al. Evaluation of the migraine treatment sumatriptan/naproxen sodium on blood pressure following long-term administration. J Clin Hypertens. 2011 Dec;13(12):910-6.Полный текст  Аннотация

243. Weisz MA, el-Raheb M, Blumenthal HJ. Home administration of intramuscular DHE for the treatment of acute migraine headache. Headache. 1994 Jun;34(6):371-3. Аннотация

244. Silberstein SD. The pharmacology of ergotamine and dihydroergotamine. Headache. 1997;37(suppl 1):S15-25. Аннотация

245. Acs N, Banhidy F, Puho E, et al. A possible dose-dependent teratogenic effect of ergotamine. Reprod Toxicol. 2006 Oct;22(3):551-2. Аннотация

246. Raymond GV. Teratogen update: ergot and ergotamine. Teratology. 1995 May;51(5):344-7. Аннотация

247. Fibrosis due to ergot derivatives: exposure to risk should be weighed up. Prescrire Int. 2002 Dec;11(62):186-9. Аннотация

248. Joffe H, Cohen LS, Suppes T, et al. Longitudinal follow-up of reproductive and metabolic features of valproate-associated polycystic ovarian syndrome features: a preliminary report. Biol Psychiatry. 2006 Dec 15;60(12):1378-81. Аннотация

249. Rasgon N. The relationship between polycystic ovary syndrome and antiepileptic drugs: a review of the evidence. J Clin Psychopharmacol. 2004 Jun;24(3):322-34. Аннотация

250. Silberstein SD. Control of topiramate-induced paresthesias with supplemental potassium. Headache. 2002 Jan;42(1):85. Аннотация

251. Lipton RB, Silberstein S, Dodick D, et al. Topiramate intervention to prevent transformation of episodic migraine: The topiramate INTREPID study. Cephalalgia. 2011 Jan;31(1):18-30. Аннотация

252. Jackson JL, Shimeall W, Sessums L, et al. Tricyclic antidepressants and headaches: Systematic review and meta-analysis. BMJ. 2010 Oct 20;341:c5222.Полный текст  Аннотация

253. Markley HG. Verapamil and migraine prophylaxis: mechanisms and efficacy. Am J Med. 1991 May 17;90(5A):48-53S. Аннотация

254. Bulut S, Berilgen MS, Baran A, et al. Venlafaxine versus amitriptyline in the prophylactic treatment of migraine: randomized, double-blind, crossover study. Clin Neurol Neurosurg. 2004 Dec;107(1):44-8. Аннотация

255. Adelman LC, Adelman JU, Von Seggern R, et al. Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: a retrospective study in a clinical setting. Headache. 2000 Jul-Aug;40(7):572-80. Аннотация

256. Nascimento ED. Prophylaxis of migraine: open study with venlafaxine in 42 patients [in Portuguese]. Arq Neuropsiquiatr. 1998 Dec;56(4):744-6. Аннотация

257. Pringsheim T, Davenport W, Mackie G, et al. Canadian Headache Society guideline for migraine prophylaxis. Can J Neurol Sci. 2012 Mar;39(2 suppl 2):S1-59.Полный текст  Аннотация

258. Martelletti P, Giamberardino MA. Advances in orally administered pharmacotherapy for the treatment of migraine. Expert Opin Pharmacother. 2019 Feb;20(2):209-18. Аннотация

259. Lipton RB, Croop R, Stock EG, et al. Rimegepant, an oral calcitonin gene-related peptide receptor antagonist, for migraine. N Engl J Med. 2019 Jul 11;381(2):142-9.Полный текст  Аннотация

260. Croop R, Goadsby PJ, Stock DA, et al. Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial. Lancet. 2019 Aug 31;394(10200):737-45. Аннотация

261. Dodick DW, Lipton RB, Ailani J, et al. Ubrogepant for the treatment of migraine. N Engl J Med. 2019 Dec 5;381(23):2230-41.Полный текст  Аннотация

262. Reuter U, McClure C, Liebler E, et al. Non-invasive neuromodulation for migraine and cluster headache: a systematic review of clinical trials. J Neurol Neurosurg Psychiatry. 2019 Jul;90(7):796-804.Полный текст  Аннотация

263. Chou DE, Gross GJ, Casadei CH, et al. External trigeminal nerve stimulation for the acute treatment of migraine: open-label trial on safety and efficacy. Neuromodulation. 2017 Oct;20(7):678-83. Аннотация

264. Goadsby PJ, de Coo IF, Silver N, et al. Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: a randomized, double-blind, sham-controlled ACT2 study. Cephalalgia. 2018 Apr;38(5):959-69.Полный текст  Аннотация

265. Simon B, Blake J. Mechanism of action of non-invasive cervical vagus nerve stimulation for the treatment of primary headaches. Am J Manag Care. 2017 Nov;23(17 suppl):S312-6.Полный текст  Аннотация

266. Goadsby PJ, Wietecha LA, Dennehy EB, et al. Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine. Brain. 2019 Jul 1;142(7):1894-904.Полный текст  Аннотация

267. Ashina M, Saper J, Cady R, et al. Eptinezumab in episodic migraine: a randomized, double-blind, placebo-controlled study (PROMISE-1). Cephalalgia. 2020 Mar;40(3):241-54.Полный текст  Аннотация

268. Lipton RB, Goadsby PJ, Smith J, et al. Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2. Neurology. 2020 Mar 31;94(13):e1365-77.Полный текст  Аннотация

269. Ho KWD, Przkora R, Kumar S. Sphenopalatine ganglion: block, radiofrequency ablation and neurostimulation - a systematic review. J Headache Pain. 2017 Dec 28;18(1):118.Полный текст  Аннотация

270. Cady RK, Saper J, Dexter K, et al. Long-term efficacy of a double-blind, placebo-controlled, randomized study for repetitive sphenopalatine blockade with bupivacaine vs. saline with the Tx360 device for treatment of chronic migraine. Headache. 2015 Apr;55(4):529-42.Полный текст  Аннотация

271. Mojica J, Mo B, Ng A. Sphenopalatine ganglion block in the management of chronic headaches. Curr Pain Headache Rep. 2017 Jun;21(6):27. [Erratum in: Curr Pain Headache Rep. 2017 Nov;21(12 ):53.] Аннотация

272. Bhola R, Kinsella E, Giffin N, et al. Single-pulse transcranial magnetic stimulation (sTMS) for the acute treatment of migraine: evaluation of outcome data for the UK post market pilot program. J Headache Pain. 2015;16:535.Полный текст  Аннотация

273. Lipton RB, Dodick DW, Silberstein SD, et al. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. Lancet Neurol. 2010 Apr;9(4):373-80. Аннотация

274. Lan L, Zhang X, Li X, et al. The efficacy of transcranial magnetic stimulation on migraine: a meta-analysis of randomized controlled trails. J Headache Pain. 2017 Aug 22;18(1):86.Полный текст  Аннотация

275. Vogler B, Rapoport AM, Tepper SJ, et al. Role of melatonin in the pathophysiology of migraine: implications for treatment. CNS Drugs. 2006;20(5):343-50. Аннотация

276. Leite Pacheco R, de Oliveira Cruz Latorraca C, Adriano Leal Freitas da Costa A, et al. Melatonin for preventing primary headache: a systematic review. Int J Clin Pract. 2018 Jul;72(7):e13203. Аннотация

277. Long R, Zhu Y, Zhou S. Therapeutic role of melatonin in migraine prophylaxis: a systematic review. Medicine (Baltimore). 2019 Jan;98(3):e14099.Полный текст  Аннотация

278. Gonçalves AL, Martini Ferreira A, Ribeiro RT, et al. Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention. J Neurol Neurosurg Psychiatry. 2016 Oct;87(10):1127-32.Полный текст  Аннотация

279. Aurora SK, Silberstein SD, Kori SH, et al. MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine. Headache. 2011 Apr;51(4):507-17. Аннотация

280. Buettner C, Nir RR, Bertisch SM, et al. Simvastatin and vitamin D for migraine prevention: a randomized, controlled trial. Ann Neurol. 2015 Dec;78(6):970-81. Аннотация

281. Zhang H, Yang X, Lin Y, et al. The efficacy of greater occipital nerve block for the treatment of migraine: A systematic review and meta-analysis. Clin Neurol Neurosurg. 2018 Feb;165:129-33. Аннотация

282. Lipton RB, Bigal ME. The epidemiology of migraine. Am J Med. 2005 Mar;118 Suppl 1:3-10S. Аннотация

283. Lipton RB, Silberstein SD, Saper JR, et al. Why headache treatment fails. Neurology. 2003 Apr 8;60(7):1064-70. Аннотация

284. Modgill G, Jette N, Wang JL, et al. A population-based longitudinal community study of major depression and migraine. Headache. 2012 Mar;52(3):422-32. Аннотация

285. Yang Y, Zhao H, Boomsma DI, et al. Molecular genetic overlap between migraine and major depressive disorder. Eur J Hum Genet. 2018 Aug;26(8):1202-16.Полный текст  Аннотация

286. Vécsei L, Szok D, Nyári A, et al. Treating status migrainosus in the emergency setting: what is the best strategy? Expert Opin Pharmacother. 2018 Oct;19(14):1523-31. Аннотация

287. Schürks M, Rist PM, Bigal ME, et al. Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ. 2009 Oct 27;339:b3914.Полный текст  Аннотация

288. Bono G, Minonzio G, Mauri M, et al. Complications of migraine: migrainous infarction. Clin Exp Hypertens. 2006 Apr-May;28(3-4):233-42. Аннотация

289. Parisi P, Striano P, Trenité DG, et al. 'Ictal epileptic headache': recent concepts for new classifications criteria. Cephalalgia. 2012 Jul;32(9):723-4. Аннотация

290. Nappi G, Jensen R, Nappi RE, et al. Diaries and calendars for migraine. A review. Cephalalgia. 2006 Aug;26(8):905-16. Аннотация

291. Sun-Edelstein C, Mauskop A. Foods and supplements in the management of migraine headaches. Clin J Pain. 2009 Jun;25(5):446-52. Аннотация

Использование этого контента попадает под действие нашего заявления об отказе от ответственности